Biotech’s top money raisers: 2024

Monday, March 3, 2025 – ... GLP-1 drugs—including an injectable GLP-1/GIP receptor dual agonist and an oral small-molecule GLP-1 receptor agonist, both clinical-stage ...

Monday, March 3, 2025 – ... GLP-1 drugs—including an injectable GLP-1/GIP receptor dual agonist and an oral small-molecule GLP-1 receptor agonist, both clinical-stage ...

Monday, March 3, 2025 – Dr Priya Jaisinghani discusses the benefits of GLP-1 therapy beyond glycemic control and weight management.

Monday, March 3, 2025 – Select Healthy Choice frozen meal packages get a makeover with an "On Target" nutritional badge to target the 15.5 million US adults taking GLP-1 ...

Monday, March 3, 2025 – ... compounded GLP-1 weight-loss drugs that are cheaper than the authentic prescription versions like Zepbound and Ozempic. These ads …

Monday, March 3, 2025 – ... CU Researcher Studying Effects of GLP-1 Drugs on Alcohol Addiction. by Greg Glasgow | Feb 7, 2025 ...

Monday, March 3, 2025 – Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 ...

Monday, March 3, 2025 – Among women, it altered levels of GLP-1, reducing satiety, meaning women felt less full after eating. So what foods should people eat if they want ...

Monday, March 3, 2025 – ... semaglutide shortage had been resolved. Semaglutide is the active ingredient in weight loss meds like Ozempic and Wegovy, and compounding is legal ...

Monday, March 3, 2025 – If successful, these drugs could be used as alternatives to or in combination with marketed drugs like Novo's Wegovy and Lilly's Zepbound to increase ...

Monday, March 3, 2025 – Many people who have tried to lose weight by cutting calories are familiar with this frustrating reality: At some point, the body stops shedding pounds. It senses the reduced calorie intake and responds by slowing down metabolism, causing it to burn fewer calories than before the diet.